Chronic Lymphocytic Leukemia (CLL) with Eugen Tausch

About this episode

This episode features a discussion on the evolving treatment landscape of chronic lymphocytic leukemia with expert Dr. Eugen Tausch.

In this episode of HealthTalk TV, we take a deep dive into the rapidly evolving treatment landscape of chronic lymphocytic leukemia (CLL). Host Lars Brock Nilsen is joined by Dr. Eugen Tausch, a leading international expert in CLL at the University Hospital in Ulm, to discuss how the field is moving away from chemotherapy and toward targeted, fixed-duration therapies — and what this means for patients in clinical practice. Together, they explore the key questions shaping CLL treatment today: how do you choose between continuous BTK inhibitor therapy and time-limited venetoclax-based combinations? What role should patient preferences play? And what does the latest clinical trial data tell us about the best strategy for different patient profiles? Topics covered in this episode: • What is CLL, and why is its course so heterogeneous? • The shift from chemoimmunotherapy to targeted therapies • BTK inhibitors vs. venetoclax-based combinations: how to choose • The importance of genetic risk factors (IGHV, TP53, del17p) • Patient involvement and shared decision-making • Key findings from the CLL17 trial • Treatment sequencing and managing relapse • Non-covalent BTK inhibitors and…

People in this episode

Host: Lars Brock Nilsen

Guest: Dr. Eugen Tausch

Topics covered

• Chronic Lymphocytic Leukemia
• targeted therapies
• BTK inhibitors
• venetoclax-based combinations
• patient preferences
• clinical trial data
• treatment sequencing

Keywords

• CLL
• chemotherapy
• targeted therapies
• BTK inhibitors
• venetoclax
• clinical trials
• patient involvement

Mentioned in this episode

Organizations: University Hospital in Ulm

More episodes of HealthTalk-podcasten

• KLL i Norge: – Cellegift? «Ingen bør få det» | Andrea Lenartova, Oslo universitetssykehus · June 10, 2026 · 33 min
• ASCO 2026 oppsummert: Lunge- og brystkreft – med Helland, Grønberg og Naume · June 5, 2026 · 37 min
• Benskjørhet - Den foreldreløse sykdommen – Med Mikkel Pretorius og Frede Frihagen · May 13, 2026 · 46 min
• I utrygge tider, er vi beredt? – Panelsamtale med Helsedirektoratet, LMI, PST og Forsvaret · April 30, 2026 · 17 min
• Miljøvennlig behandling av astma og kols med Christer Janson · April 16, 2026 · 22 min
• «Studielegen»: Episode 2 - Fredrik Schjesvold (Oslo Myelomatosesenter) · April 1, 2026 · 10 min